Showing results (6071-6080 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 25, 2012
NHE-1: a promising target for novel anti-cancer therapeuticsSer Yue Loo, Michelle Ker Xing Chang, Charis Sui Huay Chua, et al.Current Pharmaceutical Design|February 25, 2012
Translational research of photodynamic therapy with acridine orange which targets cancer acidityKatsuyuki Kusuzaki, Shigekuni Hosogi, Eishi Ashihara, et al.Current Pharmaceutical Design|February 25, 2012
Physiology, pharmacology and pathophysiology of the pH regulatory transport proteins NHE1 and NBCn1: similarities, differences, and implications for cancer therapyE Boedtkjer, L Bunch, S F PedersenCurrent Pharmaceutical Design|August 25, 2011
Developments in imaging technologies related to hypertensive cardiovascular diseasesMaria Filomena Santarelli, Linda Landini, Vincenzo Positano, et al.Current Pharmaceutical Design|August 25, 2011
Markers of arrhythmogenic risk in hypertensive subjectsAndrea Barison, Giuseppe Vergaro, Luigi Emilio Pastormerlo, et al.Current Pharmaceutical Design|August 25, 2011
Blood pressure and vascular alterations with growth in childhoodStefano Masi, Alexander Jones, Marietta Charakida, et al.Current Pharmaceutical Design|August 25, 2011
Hypertension in the elderly: an evidence-based reviewA Virdis, R M Bruno, M Fritsch Neves, et al.Current Pharmaceutical Design|August 25, 2011
Endothelial progenitor cells in prehypertensionRossella Di Stefano, Maria Chiara Barsotti, Francesca Felice, et al.Current Pharmaceutical Design|August 26, 2011
Immunotherapy-based strategies for the treatment of autoimmune diabetes: searching for the cureBrett E Phillips, Massimo TruccoCurrent Pharmaceutical Design|August 26, 2011
The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptorMario Rotondi, Luca ChiovatoPageof 1,008